DOVER ($DOV) is expected to release its quarterly earnings data on Thursday, January 29th before market open, per Finnhub. Analysts are expecting revenue of $2,102,967,460 and earnings of $2.51 per share.
You can see Quiver Quantitative's $DOV stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
DOVER Insider Trading Activity
DOVER insiders have traded $DOV stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $DOV stock by insiders over the last 6 months:
- IVONNE M CABRERA (SVP, General Counsel & Secr.) sold 2,630 shares for an estimated $501,815
- CHRISTOPHER B. WOENKER (Senior VP & CFO) sold 1,627 shares for an estimated $302,695
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DOVER Revenue
DOVER had revenues of $2.1B in Q3 2025. This is an increase of 4.75% from the same period in the prior year.
You can track DOV financials on Quiver Quantitative's DOV stock page.
DOVER Hedge Fund Activity
We have seen 491 institutional investors add shares of DOVER stock to their portfolio, and 461 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 846,920 shares (+74.2%) to their portfolio in Q3 2025, for an estimated $141,291,663
- FIRST TRUST ADVISORS LP removed 819,198 shares (-47.7%) from their portfolio in Q3 2025, for an estimated $136,666,802
- CITADEL ADVISORS LLC removed 728,181 shares (-72.0%) from their portfolio in Q3 2025, for an estimated $121,482,436
- ASSENAGON ASSET MANAGEMENT S.A. removed 600,939 shares (-91.6%) from their portfolio in Q4 2025, for an estimated $117,327,330
- QUBE RESEARCH & TECHNOLOGIES LTD added 520,211 shares (+65.2%) to their portfolio in Q3 2025, for an estimated $86,786,801
- PRICE T ROWE ASSOCIATES INC /MD/ added 489,974 shares (+42.5%) to their portfolio in Q3 2025, for an estimated $81,742,362
- MILLENNIUM MANAGEMENT LLC removed 410,611 shares (-43.7%) from their portfolio in Q3 2025, for an estimated $68,502,233
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DOVER Congressional Stock Trading
Members of Congress have traded $DOV stock 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $DOV stock by members of Congress over the last 6 months:
- REPRESENTATIVE JULIE JOHNSON has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 12/18, 11/13, 08/14.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
DOVER Analyst Ratings
Wall Street analysts have issued reports on $DOV in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Oppenheimer issued a "Outperform" rating on 11/14/2025
- JP Morgan issued a "Overweight" rating on 10/15/2025
To track analyst ratings and price targets for DOVER, check out Quiver Quantitative's $DOV forecast page.
DOVER Price Targets
Multiple analysts have issued price targets for $DOV recently. We have seen 7 analysts offer price targets for $DOV in the last 6 months, with a median target of $205.0.
Here are some recent targets:
- Bryan Blair from Oppenheimer set a target price of $232.0 on 01/26/2026
- Stephen Tusa from JP Morgan set a target price of $230.0 on 01/16/2026
- Julian Mitchell from Barclays set a target price of $205.0 on 01/07/2026
- Joseph O'Dea from Wells Fargo set a target price of $205.0 on 01/07/2026
- Amit Mehrotra from UBS set a target price of $256.0 on 01/05/2026
- Christopher Snyder from Morgan Stanley set a target price of $195.0 on 10/28/2025
- Deane Dray from RBC Capital set a target price of $198.0 on 10/24/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
